# Bristle

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bristle

- Industry: Medical Devices & Equipment
- Headquarters: San Francisco, US
- Website: www.bristlehealth.com
- Total disclosed funding: $3M
- Latest round: Seed (Jul 25, 2022)
- Investors on record: 2

## About

Based in California, US, and founded in 2022 by CEO Danny Grannick, David Lin, Brian Maurer, and Shivam Patel, Bristle, Inc., a.k.a. Bristle is a health-tech company that provides at-home saliva tests for oral health to measure the bacteria that cause bad breath, tooth decay, and gum inflammation. In July 2022, Bristle, Inc. raised USD 3 million in seed funding led by Initialized Capital, with participation from Y Combinator and an individual investor.

The company provides an oral health test kit that measures more than 100 bacteria in an individual’s saliva that contribute to tooth decay, gum inflammation, and halitosis (bad breath). Once conducting the test, individuals can reach the company’s oral health experts to get a care plan, personalized diet plan, and products and hygiene recommendations.

Bristle generates revenue from the sale of oral health test kits through its online platform at USD 119.

The company is planning to explore the potential to add B2B (business to business) lines of business.

## Funding rounds

- Seed, Jul 25, 2022, $3M — Y Combinator, Initialized Capital

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Initialized Capital (https://capitalatlas.ai/funds/initialized-capital) — Seed